A case of generalized pustular psoriasis treated with topical tacrolimus

Archives of Dermatology

Volumn 139, Issue 9, 2003, Pages 1219-

  Ishiko, Akira ^a   Yokoyama, Tomoaki ^a   Tanikawa, Akiko ^a   Amagai, Masayuki ^a   Nagao, Keisuke ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; DAPSONE; PREDNISOLONE; STEROID; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG POTENCY; FEMALE; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; KIDNEY FUNCTION; LIVER FUNCTION; PRIORITY JOURNAL; PSORIASIS VULGARIS; PUSTULAR PSORIASIS; SKIN BIOPSY; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; CALCITRIOL; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; PSORIASIS; TACROLIMUS;

EID: 0141596175     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.9.1219-a     Document Type: Article

References (5)

1. Bos J, Witkamp L, Zonnevald I, et al. Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study: the European FK 506 Multicentre Psoriasis Study Group. Arch Dermatol. 1996;132:419-423.
2. Ruzicka T, Assmann T, Homey B. Tacrolimus: the drug for the turn of the millennium? Arch Dermatol 1999;135:574-580.
3. Zonneveld IM, Rubins A, Jablonska S, et al. Topical tacrolimus is not effective in chronic plaque psoriasis. Arch Dermatol. 1998;134:1101-1102.
4. Plosker GL, Foster RH. Tacrolimus. Drugs. 2000;59:323-389.
5. Gupta A, Adamiak A, Chow M. Tacrolimus: a review of its use for the management of dermatoses. J Eur Acad Dermatol Venereol. 2002;16:100-114.